You are here

Ztalmy

Marinus cuts 45% of staff after key medicine stumbled in pair of phase 3 trials

Fierce Pharma

Wed, 11/13/24 - 07:29 pm

Marinus Pharmaceuticals

First Therapy Approved for Marinus and Seizures Associated with CDD

BioSpace

Mon, 03/21/22 - 10:43 am

Marinus Pharmaceutical